Frontlight ResearchEarly access
Taking peopleNo phase
Post-market Clinical Trial of the Dominus® Stent-Graft
Key facts
- Who runs it
- Braile Biomedica Ind. Com. e Repr. Ltda.
- Where
- Brazil3 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 24 Oct 2023
- Expected to end
- 28 Feb 2029
- Type of study
- Observational
- Treatments tested
- Stent-Graft Dominus® Endoprosthesis
- Record updated
- 22 August 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- 18 years of age or older
- Patients treated with the Dominus® Stent-Graft Endoprosthesis in accordance with its Instructions for Use
- Patient available for appropriate follow-up times for the study duration
- Informed patient about the nature of the study, agreeing to its provisions, and signing the informed consent
Who cannot take part
- Patient currently participating in another clinical study of drug or medical device
- Life expectancy less than 12 months
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Real-world clinical trial evidence post-market, evaluating the safety and efficacy of the Dominus® StentGraft Endoprosthesis in treating thoracic aortic diseases, following the Instructions for Use
Treatments tested
- Stent-Graft Dominus® Endoprosthesis
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Multicenter Study Collecting Post-market Clinical Data on the Dominus® Stent-Graft for Treating Thoracic Aortic Diseases
- Record updated
- 22 August 2024